FindTrial
Sign In

Risk of Osteoarthritis of the Knee at Least 5 Years After ACL Reconstruction: Comparative Study Between an Isolated ACL Reconstruction and a Reconstruction Combining ACL and ALL

Risk of Osteoarthritis of the Knee at Least 5 Years After ACL Reconstruction: Comparative Study Between an Isolated ACL Reconstruction and a Reconstruction Combining ACL and ALL

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05123456
Enrollment
180
Registered
2021-11-17
Start date
2020-04-15
Completion date
2021-12-15
Last updated
2021-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACL, ALL, Anterior Curciate Ligament, Anterolateral Ligament, Knee Injuries

Brief summary

The main objective of this study is to compare, with a minimum follow-up of 5 years, the prevalence of femoro-tibial osteoarthritis after an isolated ACL ligamentoplasty or after an ACL ligamentoplasty combining ACL and ALL.

Interventions

PROCEDURERadiography

Comparative X-ray of the single knee at 30 ° flexion.

Sponsors

European Clinical Trial Experts Network
CollaboratorOTHER
Private Hospital Jean Mermoz
CollaboratorUNKNOWN
Ramsay Générale de Santé
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who underwent an isolated Anterior Cruciate Ligament (ACL) reconstruction or a combined ACL and anterolateral ligament reconstruction (Extra Articular Plasty) between January 1, 2011 and March 31, 2012. * Patients affiliated or beneficiaries of a social security scheme * Patients who have given their express consent.

Exclusion criteria

* Patients with pediatric ACL reconstruction technique * Patients with a complex associated gesture such as osteotomy or ligamentoplasty other than extra articular plastic surgery. * Contraindication to a radio control (pregnancy) * Patient's refusal to participate in the study * Protected patients: Adults under guardianship, curatorship or other legal protection, deprived of their liberty by judicial or administrative decision; Pregnant, breastfeeding or parturient woman; Hospitalized without consent.

Design outcomes

Primary

MeasureTime frameDescription
Assessment of the prevalence of femoro-tibial osteoarthritis1 dayThe prevalence of femoro-tibial osteoarthritis will be assessed by the percentage of patients with cartilage damage to the femoro-tibial compartments on a single X-ray of the face compared to 30 °of flexion.

Countries

France

Contacts

Primary ContactJean-François Oudet
jf.oudet@ecten.eu0683346567
Backup ContactMarie-Hélène Barba
mh.barba@ecten.eu

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026